Health Law Workshop: Rachel Sachs

Monday, April 13, 2015 5:00 PM
Health Law Workshops
2014-2015
Griswold Hall, Room 110
1525 Massachusetts Ave., Cambridge, MA

Presentation Title: "Prescription Drug Reimbursement as Innovation Incentive" Rachel Sachs is an Academic Fellow at the Petrie-Flom Center. She earned her…

Read More

Health Law Workshop: Liran Einav

Monday, February 09, 2015 5:00 PM
Health Law Workshops
2014-2015
Griswold Hall, Room 110
1525 Massachusetts Ave., Cambridge, MA

Presentation Title: "The Response of Drug Expenditure to Non-Linear Contract Design: Evidence from Medicare Part D" (co-authors, Amy Finkelstein and Paul…

Read More

SAVE THE DATE: Third Annual Health Law Year in P/Review

Friday, January 30, 2015 9:00 AM - 5:00 PM
Conferences
2014-2015

At our Third Annual Health Law Year in P/Review, we will welcome experts discussing major developments during 2014 and what to watch…

Read More

Emerging Issues and New Frontiers for FDA Regulation

Monday, October 20, 2014 8:00 AM - 5:00 PM
Conferences
2014-2015
Washington, DC

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Food and Drug Law Institute are pleased to…

Read More

A Conversation with the HHS Office of the Inspector General

Tuesday, September 30, 2014 12:00 PM
Lectures and Panels
2014-2015
Wasserstein Hall, Room 3018
1585 Massachusetts Ave., Cambridge, MA

Please join the Petrie-Flom Center for a conversation with the Boston office of the U.S. Department of Health and Human Services…

Read More

Health Law Workshop: Benjamin Roin

Monday, September 29, 2014 5:00 PM
Health Law Workshops
2014-2015
Griswold Hall, Room 110
1525 Massachusetts Ave., Cambridge, MA

Presentation Topic: "Solving the Problem of New Uses" Benjamin N. Roin is Assistant Professor of Technological Innovation, Entrepreneurship, and Strategic Management at…

Read More

Health Law Workshop: Thomas McGuire

Monday, September 22, 2014 5:00 PM
Health Law Workshops
2014-2015
Griswold Hall, Room 110
1525 Massachusetts Ave., Cambridge, MA

Download the Presentation Topic Paper: Do "Reverse Payment" Settlements of Brand-Generic Patent Disputes in the Pharmaceutical Industry Constitute an Anticompetitive Pay…

Read More

Post-Trial Responsibilities:
Ethics and Implementation

Thursday, September 18, 2014 7:30 AM - 5:30 PM
Conferences
2014-2015
Wasserstein Hall, Milstein East AB
1585 Massachusetts Ave., Cambridge, MA

Driving Directions

Registration for the conference is almost closed! Register online. Please make sure to read the Hypothetical Post-Trial Scenarios prior to the event.…

Read More

How Catholic Insurance Companies Outsource Contraceptive Coverage

NPR, September 17, 2014
by Julie Rovner

Catholic and other religious hospitals and universities have been arguing in federal court for much of the past two years that they shouldn't have to offer or facilitate birth control…

Read More

A New Way Insurers are Shifting Costs to the Sick

ProPublica, September 17, 2014
by Charles Ornstein

Health insurance companies are no longer allowed to turn away patients because of their pre-existing conditions or charge them more because of those conditions. But some health policy experts say…

Read More

Patients Vulnerable When Cash-Strapped Scientists Cut Corners

NPR, September 15, 2014
by Richard Harris

[...] Most of the experimental ALS drugs, it turns out, undergo very perfunctory testing in animals before moving into human tests — based on flimsy evidence. Story Landis, director of…

Read More

Maker of Hepatitis C Drug Strikes Deal on Generics for Poor Countries

New York Times, September 15, 2014
by Gardiner Harris

The maker of one of the costliest drugs in the world announced on Monday that it had struck agreements with seven Indian generic drug makers to sell lower-cost versions of…

Read More

An Interview with I. Glenn Cohen on Controversial Health Issues

PBS.org, September 9, 2014
by Tavis Smiley, interviewing I. Glenn Cohen (Faculty Director)

In an interview with PBS.org, Faculty Director I. Glenn Cohen, sat down with Tavis Smiley to discuss important health issues, such as experimental Ebola drugs and prescription opiate use in the U.S.…

Read More

D.E.A. to Allow Return of Unused Pills to Pharmacies

New York Times, September 8, 2014
by Catherine Saint Louis

Concerned by rising rates of prescription drug abuse, the Drug Enforcement Administration announced Monday that it would permit consumers to return unused prescription medications like opioid painkillers to pharmacies. The…

Read More

Experimental Vaccine for Chikungunya Passes First Test

NPR, August 18, 2014
by Michaeleen Doucleff

Scientists have taken the first steps to developing a vaccine for chikungunya — an emerging mosquito-borne virus that has infected more than a half million people in the Western Hemisphere…

Read More

West Africa’s Ebola Epidemic Spreads

On Point , August 18, 2014
by Jane Clayson

More than one thousand people dead, more than two thousand infected. Ebola continues to spread across West Africa: Liberia, Sierra Leone, Guinea and Nigeria. The worst outbreak in history.  And still not…

Read More

Ebola Crisis and Rationing

CCTV Mandarin, August 13, 2014
by CCTV Broadcaster, interviewing I. Glenn Cohen (Faculty Director)

Faculty Director I. Glenn Cohen appeared on CCTV Mandarin to discuss the rationing and usage of experimental drugs for the Ebola outbreak.

Read More

Ethical to use untested Ebola drugs, says WHO:

BBC News, August 12, 2014

The WHO said it was ethical in light of the scale of the outbreak and high number of deaths - more than 1,000 people have died in West Africa. The…

Read More

Medical ethicists to meet on use of experimental Ebola drugs:

Al Jazeera America, August 8, 2014
by Courtney Brooks

Medical ethicists will meet next week to discuss the use of experimental medicines in the West Africa Ebola outbreak. The World Health Organization (WHO) announced the talks in the wake…

Read More

US big-data health network launches aspirin study

Nature, August 6, 2014
by Sara Reardon, quoting I. Glenn Cohen (Faculty Director)

From the article: One of the largest big-data experiments in health care has set its first research target. The leaders of the Patient-Centered Outcomes Research Institute (PCORI) in Washington DC…

Read More

US big-data health network launches aspirin study

Nature, August 6, 2014
by Sara Reardon, quoting I. Glenn Cohen (Faculty Director)

From the article: One of the largest big-data experiments in health care has set its first research target. The leaders of the Patient-Centered Outcomes Research Institute (PCORI) in Washington DC…

Read More

The Recovering Americans and the ‘Top Secret’ Ebola Treatment:

Atlantic, August 4, 2014
by James Hamblin

Because Kent Brantly is a physician who has watched people die of Ebola, there was an especially chilling prescience to his assessmentlast week, between labored breaths: "I am going to die."…

Read More

Executed Arizona Inmate Got 15 Times Standard Dose, Lawyers Say

New York Times, August 1, 2014
by Fernanda Santos

PHOENIX — Lawyers for an inmate who was executed last month by lethal injection said Friday that his executioners injected him with 15 times the standard dose of a sedative and a…

Read More

How patent reform’s fraught politics have left USPTO still without a boss

The Washington Post, July 30, 2014
by Nancy Scola, quoting W. Nicholson Price II (Affiliated Faculty)

From the article: [...] The controversy began in late June when rumors started to trickle out that the White House would nominate Philip S. Johnson to lead the USPTO [...] And so…

Read More

Appeals court rules FDA can continue allowing antibiotics in animal feed:

Al Jazeera America, July 24, 2014
by Marisa Taylor

A federal appeals court ruled Thursday that the U.S. Food and Drug Administration can continue its policy of allowing widespread antibiotic use in animal feed – a practice believed by…

Read More

Arizona Takes Nearly 2 Hours to Execute Inmate

New York Times, July 23, 2014
by Erik Eckhom

In another unexpectedly prolonged execution using disputed lethal injection drugs, a condemned Arizona prisoner on Wednesday repeatedly gasped for one hour and 40 minutes, according to witnesses, before dying at…

Read More

Clinical Trials and the Right to Remain Silent

JAMA, July 21, 2014
by Michelle Mello, JD, PhD, MPhil and I. Glenn Cohen, JD (Faculty Director)

I. Glenn Cohen has coauthored a new Invited Commentary piece in JAMA on access to clinical trial data. From the article: In this issue of JAMA Internal Medicine, Kernan et al chronicle…

Read More

Big Data Peeps At Your Medical Records To Find Drug Problems

NPR, July 21, 2014
by Nell GreenfieldBoyce

No one likes it when a new drug in people's medicine cabinets turns out to have problems — just remember the Vioxx debacle a decade ago, when the painkiller was…

Read More

Justice Department Indicts FedEx in a Drug-Shipping Inquiry

New York Times, July 17, 2014

WASHINGTON — FedEx, the world’s second-largest package-delivery company, was indicted Thursday in connection with a Justice Department investigation into illegal pharmaceutical shipments, according to a person with knowledge of the…

Read More

Synthetic cannabis ‘not medicinal’, EU top court says

BBC News, July 10, 2014

The EU's top court says designer drugs that mimic cannabis, which are already illegal in many countries, cannot be classed as medicinal. If a drug is not "medicinal" then it…

Read More

Last-Resort Antibiotics In Jeopardy As Use Rises Globally

NPR, July 9, 2014
by Michaeleen Doucleff

The total doses of antibiotics sold in clinics and pharmacies around the world rose 36 percent from 2000 to 2010, scientists reported Wednesday. The finding, published in The Lancet Infectious Disease, comes from the first…

Read More

Complaint Says Insurance Plans Discriminate Against HIV Patients

NPR, July 8, 2014
by Michelle Andrews

Four Florida insurers allegedly discriminate against people with HIV/AIDS by structuring their prescription drug benefits so that patients are discouraged from enrolling, according to a complaint filed by health advocacy…

Read More

Politicians’ Prescriptions for Marijuana Defy Doctors and Data

New York Times, June 26, 2014
by Catherine Saint Louis

New York moved last week to join 22 states in legalizing medical marijuana for patients with a diverse array of debilitating ailments, encompassing epilepsy and cancer, Crohn’s disease and Parkinson’s.…

Read More

Summer Program on Emerging Issues in Food and Drug Law

Summer Program on Emerging Issues in Food and Drug Law
O'Neill Institute for National and Global Health Law, Georgetown University

Deadline: July 14 - 18, 2014

Please join the O’Neill Institute for National and Global Health Law at Georgetown University for a one-week intensive summer institute exploring the domestic and international legal, regulatory, and policy framework shaping the safety and availability…

Read More

Medical Marijuana 101:

CommonHealth, WBUR (NPR, Boston), June 23, 2014
by Martha Bebinger

[...] The Massachusetts Medical Society opposed the statewide ballot question that made marijuana legal for medical purposes. But the society offered this course because the drug is legal now for…

Read More

Shortage Of Saline Solution Has Hospitals On Edge

NPR, June 22, 2014
by April Dembosky

[...] But it's difficult to ramp up production, explains Capt. Valerie Jensen, the director of the drug shortage program at the Food and Drug Administration. She says it's challenging to…

Read More

Dementia is ‘one of greatest enemies of humanity’ - PM

BBC News, June 19, 2014

A "big, bold global push" is needed to beat dementia, David Cameron has told a summit in London. He pledged to accelerate progress on dementia drugs, by increasing funding and…

Read More

Report: Government warnings about antidepressants may have led to more suicide attempts

Washington Post, June 18, 2014
by Brady Dennis

Government warnings a decade ago about the risks associated with children and adolescents taking antidepressants appear to have backfired, causing an increase in suicide attempts and discouraging many depressed young…

Read More

A Chinese Chemical Company And A ‘Bath Salts’ Epidemic

NPR, June 16, 2014
by Frank Langfitt

[...] Shanghai has a big, legitimate pharmaceutical industry. Power — who never actually ordered the mephedrone — says factories like Chang's branched out into recreational drugs in response to orders…

Read More

Patrick airs $20m plan to combat opioid use:

Boston Globe, June 10, 2014
by Brian MacQuarrie

Governor Deval Patrick unveiled plans Tuesday to upgrade treatment for opioid addicts, expand insurance coverage, and coordinate with the other five New England governors to stem an epidemic that has…

Read More

Under Health Law, States Serve As Testing Grounds For Innovation

Kaiser Health News, June 9, 2014

Media outlets report on a range of issues related to the measure's implementation, including how some states are finding opportunities in the overhaul to pursue their own health system changes. Also in the news, the…

Read More

Hospitals Put Pharmacists In The ER To Cut Medication Errors

NPR, June 9, 2014
by Lauren Silverman

In the emergency department at Children's Medical Center in Dallas, pharmacists who specialize in emergency medicine review each medication to make sure it's the right one in the right dose.…

Read More

Judge Voids Expansion of Discount Drug Program

New York Times, June 8, 2014
by Robert Pear

WASHINGTON — A federal judge has struck down a new rule requiring drug companies to offer certain drugs at discounted prices, saying the Obama administration had no authority to issue…

Read More

‘Millions denied end-of-life drugs’:

BBC News, June 2, 2014
by Tulip Mazumdar

Figures suggest almost 18 million people - mainly in developing countries - died in unnecessary pain in 2012. In Ethiopia, there are reports of cancer patients throwing themselves in front…

Read More

A Cholera Vaccine Halts New Cases In A Guinea Epidemic

NPR, May 28, 2014
by Richard Knox

There's new evidence that an oral cholera vaccine might help stop an epidemic in its tracks. That's the encouraging message from a study that tested a two-dose vaccine during a…

Read More

Pfizer Drops $119 Billion Bid For AstraZeneca

NPR, May 27, 2014
by Elizabeth Blair

It would have been the biggest deal the pharmaceutical industry has seen in more than a decade. But for now, it's off the table. Pfizer has withdrawn its offer to…

Read More

California Counties Sue 5 Narcotics Makers

Here & Now, NPR, May 22, 2014
by Robin Young interviewing I. Glenn Cohen (Faculty Director)

Two counties in California — Orange and Santa Clara — are suing five major drug companies, accusing them of causing the growing prescription drug epidemic across the country. The complaint,…

Read More

Defeating the ‘Superbugs’:

Al Jazeera America, May 22, 2014
by Kat McGowan

In the battle against disease-causing microbes, the bugs now seem to be winning. Antibiotic drugs, which were once so good at eliminating bacterial infections of all kinds, are rapidly losing…

Read More

Biostatistics and FDA Regulation:
The Convergence of Science and Law

Tuesday, May 20, 2014 8:00 AM - 5:00 PM
Conferences
2013-2014
Wasserstein Hall, Milstein West AB
1585 Massachusetts Ave., Cambridge, MA

Symposium Presented by the Drug Information Association (DIA), the Food and Drug Law Institute (FDLI), and the Petrie-Flom Center for Health Law Policy, Biotechnology, and…

Read More